30
NOV
2015
NW Bio Plans to Expand Board, Welcomes Woodford’s Call For Independent Investigation Of Allegations In Anonymous Internet Report
Comments : Off
BETHESDA, MD, November 30, 2015 – Northwest Biotherapeutics (NASDAQ: NWBO) (“NW Bio”), a U.S. biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced today that the Board is committed to adding an additional independent director, and the Company welcomes Neil Woodford’s call for an independent investigation of allegations in a recent anonymous internet report on NW Bio. The Company’s... Read More